Targets for inhibition of HIV replication: entry, enzyme action, release and maturation. - Wikidata - awgldk - TriplyDB

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

http://www.wikidata.org/entity/Q37979697

about

In vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysis Consensus HIV-1 FSU-A integrase gene variants electroporated into mice induce polyfunctional antigen-specific CD4+ and CD8+ T cells The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood Persistence versus reversion of 3TC resistance in HIV-1 determine the rate of emergence of NVP resistance.Human leukocyte antigen (HLA) class I down-regulation by human immunodeficiency virus type 1 negative factor (HIV-1 Nef): what might we learn from natural sequence variants?Contributions of HIV-1 Nef to immune dysregulation in HIV-infected patients: a therapeutic target?The design of RNA binders: targeting the HIV replication cycle as a case study.Discovery of novel anti-HIV agents via Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry-based approach.

P2860

Q28486262-BEC6143B-C3E4-4C54-8CFA-37645100A344 Q28487823-8C3A3759-2330-439C-BFE4-C4F1F3E27EE2 Q33690506-6D71ED71-78C7-48D6-AD36-FE7A4C05276E Q36246775-DB4983B8-5D83-4008-AE9D-A76E98F535ED Q36404189-F44D51CC-7306-4BAF-82ED-801DE8561B07 Q38130717-EC9531A2-481A-4621-BA85-81198386247E Q38237585-26E74023-CB0B-4C3B-B0BC-2EF424202590 Q38843215-871E9A16-7F75-481D-9629-08E95B698346

P2860

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

http://www.wikidata.org/entity/Q37979697

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

@en

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

@nl

type

label

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

@en

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

@nl

prefLabel

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

@en

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

@nl

P1433

Q37979697-E4035CEE-D8F6-4697-8A3C-1D1E10E93E95

P1476

Q37979697-840D198B-A043-43D4-9189-CC48321CDAD0

P2093

Q37979697-0640534C-3211-402F-80BB-0CFA4094423F

Q37979697-246A0AEC-A759-4043-AF26-712B29727983

P2860

Q37979697-0012D637-9348-4F2A-A300-C92BBCC6B4C6

Q37979697-045F6F5B-D5E6-481D-AC7F-317F9D00A3C6

Q37979697-0612875B-FFDB-4F70-9D6F-5D1517A93BFF

Q37979697-06C96DDD-10DA-4100-A673-133CD3869F49

Q37979697-0B765BFB-3627-4BD9-9851-919E44689C09

Q37979697-0FC54592-FEF7-49EF-8F25-DDB9AE77719A

Q37979697-11CAABAE-1B3A-43F7-9279-F309B1E2B7A0

Q37979697-1232654C-DB27-4716-8187-CC72C79D94EC

Q37979697-12EE67BE-112F-4A19-BAA7-19CDA6FF28AA

Q37979697-150C6D8B-9468-4ECE-BA72-6BD87EAC00DE

P304

Q37979697-2829E6DB-0279-4B05-98BF-079B2055A698

P31

Q37979697-C5505EF0-477A-4F6F-99E6-EB1201EC0C51

P356

Q37979697-43D44988-024C-463E-AAF7-E16FDDCBFBCB

P433

Q37979697-779C2F14-701B-4916-8B0C-0B8931F8925F

P478

Q37979697-AE9A68E5-439E-43FD-B9A4-245F57303C78

P577

Q37979697-98D29EC9-19CE-4ADD-A217-2F87043858C2

P698

Q37979697-0772642B-10CA-494A-ABCF-03CB5DBC485B

P356

P1433

P1476

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

@en

P2093

Hauke Walter

http://www.w3.org/2001/XMLSchema#string

Saleta Sierra-Aragón

http://www.w3.org/2001/XMLSchema#string

P2860

The Vpr protein from HIV-1: distinct roles along the viral life cycle

Viral protein R regulates nuclear import of the HIV-1 pre-integration complex

TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans

Hepatotoxicity observed in clinical trials of aplaviroc (GW873140)

Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton

Active human immunodeficiency virus protease is required for viral infectivity

Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)

Complete nucleotide sequence of the AIDS virus, HTLV-III

Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140

Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism

P304

84-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000331995

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22286875

http://www.w3.org/2001/XMLSchema#string